Cipla Licenses HER2 Cancer Drug TQB2102 Across Emerging Markets
Cipla Limited and Sino Biopharmaceutical’s subsidiary Chia Tai Tianqing Pharmaceutical Group (CTTQ) have entered…
Trending
- World ADC Awards 2026 Shortlist Announced, Recognizing Excellence Across the ADC Industry
- Cipla Licenses HER2 Cancer Drug TQB2102 Across Emerging Markets
- FDA Approves BESREMi for Essential Thrombocythemia After 30 Years
- Teva Discusses Lower Medicaid Drug Prices With Trump Administration
- Kazia Therapeutics Raises $40 Million to Advance Paxalisib Trials
- SK Biopharmaceuticals to In-License Opakalim for Epilepsy Treatment
- FDA Accepts Kowa’s K-911 Glaucoma Drug Application for Review
- AusperBio Raises $120 Million to Advance Hepatitis B Drug
- FDA Approves LISRAYA for Adults With Dermatomyositis
- FDA Approves Mounjaro to Reduce Cardiovascular Risk in Type 2 Diabetes
Top Headlines
FDA Approves BESREMi for Essential Thrombocythemia After 30 Years
The U.S. Food and Drug Administration (FDA) has approved PharmaEssentia’s BESREMi (ropeginterferon alfa-2b-njft)…
Teva Discusses Lower Medicaid Drug Prices With Trump Administration
Teva Pharmaceuticals, the U.S. affiliate of Teva Pharmaceutical Industries Ltd., has announced a shared commitment…
Kazia Therapeutics Raises $40 Million to Advance Paxalisib Trials
Kazia Therapeutics Limited has closed an oversubscribed public offering that generated approximately $40 million in…
SK Biopharmaceuticals to In-License Opakalim for Epilepsy Treatment
SK Biopharmaceuticals has agreed to in-license opakalim, an investigational anti-seizure medicine from Biohaven, in…
FDA Accepts Kowa’s K-911 Glaucoma Drug Application for Review
The U.S. Food and Drug Administration (FDA) has accepted Kowa Pharmaceuticals America’s New Drug Application (NDA)…
Featured Event
Clinical Trials
Wainua Misses Primary Endpoint in ATTR-CM Phase III Trial
AstraZeneca and Ionis Pharmaceuticals have announced that their Phase III CARDIO-TTRansform trial evaluating Wainua (eplontersen) in patients with…
Boehringer Advances Phase III Cancer Precision Medicine Trials
Boehringer Ingelheim has announced the launch of three Phase III clinical trials aimed at advancing precision oncology for patients with some of the…
uniQure Reports Early Promise for Epilepsy Gene Therapy
uniQure has reported encouraging early clinical results from its experimental gene therapy AMT-260, offering new hope for patients living with…
Massive Bio, Optellum Partner to Advance Lung Cancer Trial Access
Massive Bio and Optellum have announced a strategic collaboration designed to connect early lung cancer detection with faster access to clinical…
Phase 3 Success Boosts Prospects for Iza-Bren
SystImmune and Bristol Myers Squibb have reported positive Phase 3 results for izalontamab brengitecan (iza-bren), an investigational bispecific…
GSK Drug Bepirovirsen Shows Promise in Redefining Chronic Hepatitis B Treatment
British pharmaceutical company GSK has reported encouraging late-stage clinical trial results for bepirovirsen, an investigational therapy for chronic…
Fast shipping, security and absolute privacy is our main goal Viagra-Buy.com/ savings on their medication from a licensed and certified pharmacy.
The best pharmacy in america Viagra-Buy.com Fast delivery, best prices and for real men
SandboxAQ Launches AI Model to Speed Drug Discovery
SandboxAQ has announced the general availability of AQPotency, an AI-powered model designed to help drug discovery…
Bristol Myers Squibb Expands AI Supercomputer for Drug Discovery
Bristol Myers Squibb (BMS) is significantly expanding its artificial intelligence capabilities with the deployment…
Drug Research
Sentynl, Mereo Partner to Advance Oral AATD Lung Disease Therapy
Sentynl Therapeutics, a U.S.-based biopharmaceutical company and wholly owned subsidiary of Zydus Lifesciences, has…
Latus Bio Raises $97 Million to Advance Gene Therapies
Latus Bio, Inc. has secured $97 million in Series A financing to accelerate the development of its gene therapy…
UK Streamlines Drug Approvals to Accelerate Patient Access
The Medicines and Healthcare products Regulatory Agency (MHRA) and National Institute for Health and Care…
Novartis Targets Breast Cancer With Novel PI3Kα Inhibitor Deal
Novartis has announced a strategic agreement with Synnovation Therapeutics, LLC to acquire SNV4818, an…
FDA Proposes New Steps to Streamline Biosimilar Drug Development
The U.S. Food and Drug Administration has announced a new regulatory initiative aimed at accelerating the…
Manufacturing
Genentech Plans $750 Million Device Manufacturing Facility in Oregon
Genentech, a member of the Roche Group, plans to invest approximately $750 million to build a new device…
Fujifilm and Taiho Partner on Next-Generation ADC Manufacturing
FUJIFILM Corporation and Taiho Pharmaceutical have formed a strategic partnership to advance manufacturing…
Cellares and SonomaBio Partner on Automated Treg Cell Therapy Manufacturing
Cellares and Sonoma Biotherapeutics have announced a new collaboration to automate the manufacturing of…
Cellares, TScan Partner on Automated TSC-101 Manufacturing
Cellares and TScan Therapeutics have entered into a strategic agreement to evaluate automated clinical…
Fujifilm Expands Stem Cell Manufacturing in Wisconsin
FUJIFILM Cellular Dynamics has inaugurated a new headquarters and induced pluripotent stem cell (iPSC) development…
Piramal, Ajinomoto Partner to Advance ADC Manufacturing Capabilities
Piramal Pharma Solutions and Ajinomoto Bio-Pharma Services have announced a strategic collaboration aimed at…
UCB Selects Georgia for Major U.S. Biologics Manufacturing Hub
UCB has announced plans to establish a major new biologics manufacturing facility in Gwinnett County, Georgia,…
LGM Pharma Expands U.S. Manufacturing With $15M Investment
LGM Pharma has announced a $9 million expansion across its U.S. manufacturing network, marking the second phase of…
Diseases
Tenaya and Alnylam Partner to Discover New Genetic Targets for Heart Disease
Clinical-stage biotechnology company Tenaya Therapeutics has announced a new research collaboration with RNA…
AstraZeneca, CSPC Partner on Next-Generation Obesity Therapies
AstraZeneca has strengthened its weight management and metabolic disease pipeline through a new strategic…
China Approves ENHERTU for Second-Line HER2-Positive Gastric Cancer
China’s National Medical Products Administration (NMPA) has approved ENHERTU® (trastuzumab deruxtecan) for the…
InterAx, Alveus Partner to Advance Next-Generation Obesity Therapy
InterAx Biotech Ltd and Alveus Therapeutics Inc. have entered into a strategic research collaboration and licensing…
Sandoz to Acquire Just-Evotec Biologics Facility in Toulouse Under New Term Sheet
Sandoz has signed a non-binding term sheet with Evotec SE to potentially acquire Just–Evotec Biologics EU SAS,…
AstraZeneca and Revna Biosciences Expand Lung Cancer Treatment Access in Ghana
Since announcing their partnership in April 2025, AstraZeneca and Revna Biosciences have made significant strides…
